<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">7707449</journal-id>
<journal-id journal-id-type="pubmed-jr-id">656</journal-id>
<journal-id journal-id-type="nlm-ta">Ann Neurol</journal-id>
<journal-id journal-id-type="iso-abbrev">Ann. Neurol.</journal-id>
<journal-title-group>
<journal-title>Annals of neurology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0364-5134</issn>
<issn pub-type="epub">1531-8249</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29283439</article-id>
<article-id pub-id-type="pmc">5876123</article-id>
<article-id pub-id-type="doi">10.1002/ana.25130</article-id>
<article-id pub-id-type="manuscript">NIHMS932164</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Homozygous Boricua <italic>TBCK</italic> Mutation Causes Neurodegeneration and Aberrant Autophagy</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Ortiz-González</surname>
<given-names>Xilma R</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tintos-Hernández</surname>
<given-names>Jesus A</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Keller</surname>
<given-names>Kierstin</given-names>
</name>
<degrees>Ms CGC</degrees>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Xueli</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Foley</surname>
<given-names>A. Reghan</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bharucha-Goebel</surname>
<given-names>Diana X</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A5">5</xref>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kessler</surname>
<given-names>Sudha K</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yum</surname>
<given-names>Sabrina W.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Crino</surname>
<given-names>Peter B.</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>He</surname>
<given-names>Miao</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wallace</surname>
<given-names>Douglas C</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bönnemann</surname>
<given-names>Carsten G.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Department of Pediatrics, Division of Neurology, The Children’s Hospital of Philadelphia, Philadelphia, PA</aff>
<aff id="A2">
<label>2</label>Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA</aff>
<aff id="A3">
<label>3</label>Center for Mitochondrial and Epigenomic Medicine, The Children’s Hospital of Philadelphia, Philadelphia, PA</aff>
<aff id="A4">
<label>4</label>Department of Pathology and Laboratory Medicine, The Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA</aff>
<aff id="A5">
<label>5</label>Neuromuscular and Neurogenetic Disorders of Childhood Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD</aff>
<aff id="A6">
<label>6</label>Department of Neurology, University of Maryland School of Medicine, Baltimore, MD</aff>
<aff id="A7">
<label>7</label>Division of Neurology, Children’s National Health System, Washington, DC</aff>
<author-notes>
<corresp id="FN1"><bold>Corresponding author:</bold> Xilma R Ortiz-Gonzalez, MD, PhD, CHOP Neurology, CTRB 10<sup>th</sup> floor, 3501 Civic Center Blvd, Philadelphia PA 19104, phone and fax: (215) 590-1719 phone; (215) 590-1771, <email>ortizgonzalez@email.chop.edu</email></corresp>
<fn fn-type="COI-statement" id="FN3">
<p><bold>Potentials Conflicts of Interest</bold>:</p>
<p>Nothing to disclose.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>26</day>
<month>1</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>1</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>1</month>
<year>2019</year>
</pub-date>
<volume>83</volume>
<issue>1</issue>
<fpage>153</fpage>
<lpage>165</lpage>
<!--elocation-id from pubmed: 10.1002/ana.25130-->
<abstract>
<sec id="S1">
<title>Objective</title>
<p id="P1">Autosomal recessive mutations in <italic>TBCK</italic> cause intellectual disability of variable severity. Although the physiologic function of TBCK remains unclear, loss-of-function mutations are associated with inhibition of mTORC1 signaling. As mTORC1 signaling is known to regulate autophagy, we hypothesized that TBCK-encephalopathy patients with a neurodegenerative course have defects in autophagic-lysosomal dysfunction.</p>
</sec>
<sec id="S2">
<title>Methods</title>
<p id="P2">Children (n=8) of Puerto Rican (Boricua) descent affected with homozygous <italic>TBCK</italic> p.R126X mutations underwent extensive neurological phenotyping and neurophysiological studies. We quantified autophagosome content in TBCK<sup>−/−</sup> patient-derived fibroblasts by immunostaining and assayed autophagic markers by Western assay. Free sialylated oligosaccharide profiles were assayed in patient’s urine and fibroblasts.</p>
</sec>
<sec id="S3">
<title>Results</title>
<p id="P3">The neurologic phenotype of children with <italic>TBCK</italic> p.R126X mutations, which we call TBCK-encephaloneuronopathy (TBCKE), include congenital hypotonia, progressive motor neuronopathy, leukoencephalopathy and epilepsy. Systemic features include coarse facies, dyslipidemia, and osteoporosis. TBCK<sup>−/−</sup> fibroblasts <italic>in vitro</italic> exhibit increased numbers of LC3+ autophagosomes, and increased autophagic flux by immunoblots. Free oligosaccharide profiles in fibroblasts and urine of TBCKE patients differ from control fibroblasts and are ameliorated by treatment with the mTORC1 activator leucine.</p>
</sec>
<sec id="S4">
<title>Interpretation</title>
<p id="P4">TBCKE is a clinically distinguishable syndrome with progressive central and peripheral nervous system dysfunction, consistently seen in patients with the p.R126X mutation. We provide evidence that inappropriate autophagy in the absence of cellular stressors may play a role in this disorder, and that mTORC1 activation may ameliorate the autophagic-lysosomal system dysfunction. Free oligosaccharide profiles could serve as a novel biomarker for this disorder as well as a tool to evaluate potential therapeutic interventions.</p>
</sec>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>